Cochrane COVID-19 Podcasts

Young man listing to Cochrane podcast via earphones connected to phone

Cochrane is preparing a series of reviews to help decision makers with their response to COVID-19. Each Cochrane podcast offers a short summary of a recent Cochrane COVID-19 review from the authors themselves. They allow everyone from healthcare professionals to patients and families to hear the latest Cochrane evidence in under five minutes. 

COVID-19 virus with podcast icon

 What is the best way to support resilience and mental well-being in frontline healthcare professionals during and after a pandemic?
At the start of the COVID-19 pandemic, we gathered the most important questions from a range of stakeholders, including clinicians, patients and researchers. These led to a string of new reviews during 2020 and one of these, published in November 2020, looks at interventions to support the resilience and mental health of frontline workers. Here’s Alex Pollock from Glasgow Caledonian University in Scotland to tell us about the review.

How accurate is chest imaging for diagnosing COVID-19?
The COVID-19 pandemic is creating challenges for diagnosis of the disease, as well as for its treatment. The rapid reviews being prepared and updated by Cochrane are covering both areas. We asked the lead author of the November 2020 versions of our review of the evidence on using imaging tests to diagnose the condition, Nayaar Islam from The Ottawa Hospital Research Institute in Canada, to describe the latest findings in this podcast.

Do blood thinners prevent people who are hospitalised with COVID-19 from developing blood clots?
In October 2020, we published the findings on the effects of anticoagulants and lead author, Ronald Flumignan from the Federal University of Sao Paulo in Brazil describes what they found in this podcast.

How effective is screening for COVID-19?
Screening programmes are in place for many conditions and the COVID-19 pandemic has led to discussions of whether people should be screened for SARS-CoV-2, which is the virus that causes COVID-19. A Cochrane rapid review from September 2020 looks at the evidence for universal screening and we asked lead author, Meera Viswanathan from RTI International in the USA to describe the findings in this podcast.

Is plasma from people who have recovered from COVID-19 an effective treatment for people with COVID-19?
In October 2020, we published our second update of the review of convalescent plasma and hyperimmune immunoglobulin and we asked its lead author, Khai Li Chai from Monash University in Australia, to tell us about the latest findings.

How accurate is chest imaging for diagnosing COVID-19?
We asked the lead author of the September 2020 review of the evidence on using imaging tests to diagnose the condition, Jean-Paul Salameh from The Ottawa Hospital Research Institute in Canada, to describe their findings in this podcast.

Does quarantine, alone or in combination with other public health measures, control coronavirus (COVID-19)?
In this podcast, lead author, Barbara Nussbaumer-Streit from Danube University Krems in Austria outlines the findings of the review of quarantine, which was originally requested by the World Health Organization and was first published in April, before being updated in September 2020.

Can travel-related control measures contain the spread of the COVID-19 pandemic?
In this podcast, lead author, Jake Burns from the University of Munich in Germany describes the findings of our review of the effects of travel-related control measures, which was published in September 2020.

Can symptoms and medical examination accurately diagnose COVID-19 disease?
Published i
n June 2020, this review examines the accuracy of using signs and symptoms to diagnose whether someone has the disease. We asked the lead author, Thomas Struyf from the KU Leuven in Belgium, to tell us why the review is needed and what they found.

What type of heart and blood vessel problems complicate COVID-19 infections, how common are they and what other medical conditions do these patients have?
In this podcast, co-author Keng Siang Lee, from the University of Bristol speaks with the first author, Pierpaolo Pellicori (photo) from the University of Glasgow in the UK about the findings.

How accurate are rapid tests for diagnosing COVID-19?
We have several reviews relevant to the diagnosis of COVID-19/ One of these, on the use of rapid point-of-care tests was updated in March 2021. Here's lead author Jacqueline Dinnes from the University of Birmingham in the UK to tell us what they found for antigen tests.

Can international travel-related control measures contain the spread of the COVID-19 pandemic?
In this podcast, lead author, Jake Burns from the University of Munich in Germany describes the latest findings of our review of the effects of control measures for international travel, which was updated in March 2021.

 

Is plasma from people who have recovered from COVID-19 an effective treatment for people with COVID-19?
In this podcast, Vanessa Piechotta speaks with one of the lead authors, Claire Iannizzi both from the University Hospital Cologne in Germany about the latest findings.

Is vitamin D an effective and safe treatment for COVID-19?
In May 2021, we published the first version of a living systematic review on the effects of vitamin D supplementation and, in this podcast, Vanessa Piechotta talks to the first author and her colleague at the University Hospital in Cologne Germany, Julia Stroehlein, about the potential effects of vitamin D and the evidence they’ve found.

Ivermectin for preventing and treating COVID-19
In July 2021, we published the first version of our review on the effects of ivermectin for the prevention and treatment of COVID-19, in a collaboration between Cochrane's Infectious Diseases and Haematological Malignancy Groups. We asked one of the authors, Maria Popp from University Hospital Wuerzburg in Germany, to tell us about their findings.

Are laboratory-made, COVID-19-specific monoclonal antibodies an effective treatment for COVID-19?
In September 2021, we published the first version of a Living Systematic Review on the effects of monoclonal antibodies for treating COVID-19 and in this podcast we speak to Nina Kreuzberger one of the lead authors, about the review, which was initiated in the Germany-wide joint projects "COVIM" and "CEOsys" and funded by the Federal Ministry of Education and Research of Germany.

You can view and search our entire catalogue of hundreds of podcasts or subscribe via iTunes for the latest updates.

 

Monday, September 20, 2021